Engoren Milo C, Habib Robert H, Zacharias Anoar, Schwann Thomas A, Riordan Christopher J, Durham Samuel J, Shah Aamir
Department of Anesthesiology, St. Vincent Mercy Medical Center, 2213 Cherry Street, Toledo, OH 43608, USA.
Eur J Cardiothorac Surg. 2005 Jul;28(1):114-9. doi: 10.1016/j.ejcts.2005.03.004. Epub 2005 Apr 7.
The joint European Society of Cardiology and American College of Cardiology consensus statement on myocardial necrosis after revascularization stated that any amount of myocardial necrosis as detected by cardiac enzymes should be labeled a myocardial infarct. However, it also stated that more data collection is necessary to better interpret the elevation of cardiac enzymes after coronary artery bypass grafting. We sought to determine if a single postoperative value of creatine kinase-myocardial band could be used as a risk factor to help predict mortality after coronary artery bypass surgery.
A retrospective analysis of prospectively collected data on 1161 patients undergoing first-time, isolated coronary artery bypass surgery utilizing normothermic cardiopulmonary bypass was conducted. Creatine kinase-myocardial band was measured the morning after surgery. Binary logistic regression, Cox proportional hazard models, and overlapping quintiles were used to illuminate the association between creatine kinase-myocardial band elevation and mortality after coronary artery bypass surgery.
We found a threshold value of creatine kinase-myocardial band, 40 ng/mL, above which elevations were associated with increased death rates. This association held after adjustment for other factors known to contribute to postoperative mortality. However, after 1 year, there was no longer a statistically significant higher mortality associated with elevated creatinine kinase-myocardial band > 40 ng/mL.
Elevation of creatine kinase-myocardial band the morning after surgery above a threshold 40 ng/mL is associated with an increased risk of mortality.
欧洲心脏病学会和美国心脏病学会关于血运重建术后心肌坏死的联合共识声明指出,心脏酶检测到的任何程度的心肌坏死都应被标记为心肌梗死。然而,该声明也指出,需要收集更多数据以更好地解释冠状动脉旁路移植术后心脏酶的升高情况。我们试图确定术后肌酸激酶同工酶的单一值是否可作为预测冠状动脉旁路手术后死亡率的危险因素。
对1161例行首次单纯冠状动脉旁路手术并采用常温体外循环的患者的前瞻性收集数据进行回顾性分析。术后次日早晨测定肌酸激酶同工酶。采用二元逻辑回归、Cox比例风险模型和重叠五分位数法来阐明肌酸激酶同工酶升高与冠状动脉旁路手术后死亡率之间的关联。
我们发现肌酸激酶同工酶的阈值为40 ng/mL,高于此值的升高与死亡率增加相关。在对其他已知导致术后死亡的因素进行调整后,这种关联依然存在。然而,1年后,肌酸激酶同工酶>40 ng/mL升高与死亡率增加不再具有统计学上的显著相关性。
术后次日早晨肌酸激酶同工酶升高超过阈值40 ng/mL与死亡风险增加相关。